GlassScriptPhysician profile
Yoko Suzuki
NPI 1366653552
$1,411.67
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $61.32 · 2021: $330 · 2022: $400 · 2023: $239 · 2024: $49.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $554.23 | 2019-2022 | |
| Galderma Laboratories, L.P. | $282.77 | 2021-2023 | |
| Abbvie INC. | $204.84 | 2020-2023 | |
| Akebia Therapeutics INC | $88.89 | 2019 | |
| Exact Sciences Corporation | $70.08 | 2023-2024 | Cologuard Collection Kit |
| Organon LLC | $31.42 | 2023 | Nexplanon |
| Merz North America, INC. | $25.64 | 2021 | |
| Hologic Sales and Service, LLC | $25.00 | 2024 | Aptima |
| Depuy Synthes Sales INC. | $24.84 | 2019 | |
| Minerva Surgical, INC | $20.64 | 2019 | |
| Mayne Pharma Commercial LLC | $19.92 | 2022 | |
| Mentor Worldwide LLC | $18.48 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.22 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $15.84 | 2019 | |
| Therapeuticsmd, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoko Suzuki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.